View in EDS

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.

Saved in:
Bibliographic Details
Title: Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.
Authors: Gordon A; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Tran A; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Fong C; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Cromarty S; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Piadel K; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Zhitkov O; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Leamon B; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Cafferkey C; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Davidson M; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Das P; Royal Derby Hospital, Derby, UK., Petty R; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK., Roques T; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Hewish M; Royal Surrey County Hospital, Guildford, UK., Morgan C; Department of Clinical Oncology, Velindre Cancer Centre, Cardiff, UK., Waddell T; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Darby S; Weston Park Cancer Centre, Sheffield, UK., Bradshaw A; Northern Centre for Cancer Care, Newcastle Upon Tyne, UK., Rao S; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Starling N; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Chau I; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Cunningham D; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK. David.cunningham@rmh.nhs.uk.
Source: British journal of cancer [Br J Cancer] 2026 Jul; Vol. 135 (2), pp. 240-247. Date of Electronic Publication: 2026 Apr 21.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42014556
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gordon+A%22">Gordon A</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Tran+A%22">Tran A</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Fong+C%22">Fong C</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Cromarty+S%22">Cromarty S</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Piadel+K%22">Piadel K</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Zhitkov+O%22">Zhitkov O</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Leamon+B%22">Leamon B</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Cafferkey+C%22">Cafferkey C</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Davidson+M%22">Davidson M</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Das+P%22">Das P</searchLink>; Royal Derby Hospital, Derby, UK.<br /><searchLink fieldCode="AU" term="%22Petty+R%22">Petty R</searchLink>; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.<br /><searchLink fieldCode="AU" term="%22Roques+T%22">Roques T</searchLink>; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.<br /><searchLink fieldCode="AU" term="%22Hewish+M%22">Hewish M</searchLink>; Royal Surrey County Hospital, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Morgan+C%22">Morgan C</searchLink>; Department of Clinical Oncology, Velindre Cancer Centre, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Waddell+T%22">Waddell T</searchLink>; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Darby+S%22">Darby S</searchLink>; Weston Park Cancer Centre, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Bradshaw+A%22">Bradshaw A</searchLink>; Northern Centre for Cancer Care, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Rao+S%22">Rao S</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Starling+N%22">Starling N</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Chau+I%22">Chau I</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Cunningham+D%22">Cunningham D</searchLink>; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK. David.cunningham@rmh.nhs.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2026 Jul; Vol. 135 (2), pp. 240-247. <i>Date of Electronic Publication: </i>2026 Apr 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42014556
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-026-03448-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 240
    Titles:
      – TitleFull: Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gordon A
      – PersonEntity:
          Name:
            NameFull: Tran A
      – PersonEntity:
          Name:
            NameFull: Fong C
      – PersonEntity:
          Name:
            NameFull: Cromarty S
      – PersonEntity:
          Name:
            NameFull: Piadel K
      – PersonEntity:
          Name:
            NameFull: Zhitkov O
      – PersonEntity:
          Name:
            NameFull: Leamon B
      – PersonEntity:
          Name:
            NameFull: Cafferkey C
      – PersonEntity:
          Name:
            NameFull: Davidson M
      – PersonEntity:
          Name:
            NameFull: Das P
      – PersonEntity:
          Name:
            NameFull: Petty R
      – PersonEntity:
          Name:
            NameFull: Roques T
      – PersonEntity:
          Name:
            NameFull: Hewish M
      – PersonEntity:
          Name:
            NameFull: Morgan C
      – PersonEntity:
          Name:
            NameFull: Waddell T
      – PersonEntity:
          Name:
            NameFull: Darby S
      – PersonEntity:
          Name:
            NameFull: Bradshaw A
      – PersonEntity:
          Name:
            NameFull: Rao S
      – PersonEntity:
          Name:
            NameFull: Starling N
      – PersonEntity:
          Name:
            NameFull: Chau I
      – PersonEntity:
          Name:
            NameFull: Cunningham D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 135
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1